LBRX Earnings & Financial Statements - LB Pharmaceuticals Inc Common Stock logo

LBRX Earnings & Financial Statements

LB Pharmaceuticals Inc Common Stock

$40.04
-$0.02(-0.05%)
45
Overall
60
Value
41
Tech
36
Quality
How is this score calculated?
Market Cap
$1.30B
Volume
405.43K
52W Range
$15.13 - $50.16
Target Price
$58.92

LBRX earnings and financial statements: LB Pharmaceuticals Inc Common Stock's income statement, balance sheet and cash flow statement, annual and quarterly.

LBRX Annual Financial Statements

LBRX income statement
Fiscal year202520242023
Operating income-$30.40M-$64.83M-$18.84M
EBITDA-$30.08M-$61.15M-$29.65M
Net income-$25.20M-$61.21M-$38.79M
EPS (diluted)$-3.13$-176.15$-21.86
LBRX balance sheet
Fiscal year202520242023
Total assets$312.93M$33.53M$45.66M
Total liabilities$11.62M$13.83M$4.16M
Shareholders’ equity$301.31M$19.70M$41.49M
Cash and equivalents$250.17M$22.98M$14.98M
Long-term debt$2.84M$3.22M-
LBRX cash flow statement
Fiscal year202520242023
Operating cash flow-$35.21M-$53.05M-$12.09M
Capital expenditure-$52.0K--
Free cash flow-$35.26M-$53.82M-$12.12M
ABCD
1SymbolPriceChangeVol
2LBRX$40.04-0.0%405.43K
3
4
5
6

Get LB Pharmaceuticals Inc Common Stock Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.